Verici Dx plc (LON:VRCI – Get Free Report)’s share price fell 12.9% during mid-day trading on Thursday . The stock traded as low as GBX 2.53 ($0.03) and last traded at GBX 2.53 ($0.03). 325,413 shares were traded during mid-day trading, a decline of 70% from the average session volume of 1,098,470 shares. The stock had previously closed at GBX 2.90 ($0.04).
Verici Dx Price Performance
The firm has a market cap of £7.66 million, a P/E ratio of -1.46 and a beta of 1.59. The company has a debt-to-equity ratio of 4.64, a current ratio of 4.54 and a quick ratio of 8.49. The firm’s 50 day moving average is GBX 3.08 and its 200 day moving average is GBX 3.78.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Recommended Stories
- Five stocks we like better than Verici Dx
- Buy P&G Now, Before It Sets A New All-Time High
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Top Biotech Stocks: Exploring Innovation Opportunities
- The 3 Most Talked About Investments on WallStreetBets Right Now
- The Role Economic Reports Play in a Successful Investment Strategy
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
